Table 2.
Gender | |
---|---|
Male | 10 |
Female | 1 |
Mean age (years, range) | 59.5 (45–71) |
Imaging patterns | |
Focal | 3 |
Diffuse | 5 |
Focal on diffuse | 3 |
Myeloma subtype | |
IgG | 8 |
IgA | 3 |
Novel agent treatment | |
Lenalidomide-based | 7 |
Bortezomib-based | 3 |
Carfilzomib-based | 1 |